### **Company Overview** **Aether Industries Limited**, incorporated in 2013 and listed in 2022, is a rapidly growing Indian specialty chemicals and advanced intermediates manufacturing company. Headquartered in Surat, Gujarat, the company specializes in complex organic chemistry and operates across pharmaceuticals, agrochemicals, material sciences, electronics, oil & gas, and high-performance photography. Aether began commercial operations in 2018 and has since achieved a **34.74% CAGR in revenue** from FY2018 to FY2025, positioning it among India’s fastest-growing specialty chemical companies. The company operates through **three core business models**: 1. **Large Scale Manufacturing (LSM)** – Proprietary molecules developed internally and produced at scale. 2. **Contract/Exclusive Manufacturing (CEM)** – Custom manufacturing for multinational clients under long-term agreements. 3. **Contract Research and Manufacturing Services (CRAMS)** – End-to-end R&D, pilot scale-up, and manufacturing for customer-driven molecules. --- ### **Financial & Operational Highlights (as of Nov 2025)** - **Revenue in FY2025 (ending March 31): ₹8,803 million** (Up from ₹6,676 million in FY2023, with CAGR of ~34.74% since 2018) - **Revenue Mix (Q2 FY26):** - CEM: **48%** - LSM: **41%** - CRAMS: **9%** - Combined CEM + CRAMS now **>55%** of total revenue - **Exports:** ~**44%** of revenue, with significant growth in North America and entry into African markets. - **Top Markets by Revenue (FY25):** - India: **60.51%** - Mexico: **10.49%** (up from 0.96% in FY24) - U.S.: **6.81%** - China: **1.59%** - **Largest Customer:** 10.00% of FY2025 revenue (down from 13.42% in FY2024), indicating improved customer diversification. - **Top 10 Customers:** 45.86% of revenue (down from 50.51% in FY2024), reflecting broadening of client base. --- ### **R&D & Innovation** Aether Industries’ core competitive advantage lies in its **strong intellectual capital and advanced R&D infrastructure**, which supports innovation, sustainability, and technology differentiation. - **R&D Investment:** - FY2024–25: ₹681 million (**7.74% of revenue**) - Peak R&D intensity reached **15.4% in FY2024**, reflecting strategic focus on innovation. - **R&D Workforce:** - 145 scientists, 141 engineers (total R&D personnel: **28.92%** of total workforce) - Led by **Dr. James Ringer**, CTO (ex-Dow Chemical, ex-Corteva, 22 USA patents) - **Current R&D Projects (Nov 2025):** ~**55 projects in progress**, including: - **40 CRAMS/CEM** (customer-driven) - **15 LSM** (proprietary development) - **Expansion Plans:** - R&D capacity expected to **more than double to 120 projects within 1.5 years** via lab expansion in Hojiwala, Surat. - Site 1 (R&D hub) is undergoing **double expansion**, currently housing **63 fume hoods** across 8 research groups. - **Engineering Labs:** - Expanding to **four engineering labs**—a rare capability among Indian chemical firms—focused on **scale-up, process intensification, continuous distillation, modular reactor design, and process safety**, not just synthesis chemistry. - **Proprietary Technologies:** - **Converge® Polyols** (licensed from Saudi Aramco): Sustainable polyols with up to **40% CO₂ content**, currently sampled by MNCs. LCA studies completed. - **Lifecycling™** (with Novoloop): Converts post-consumer polyethylene into virgin-quality monomers; **91% lower carbon footprint** vs. conventional process. - **CRAMS segment contributes 24.3% YoY growth**, driven by complex multi-step synthesis and scale-up excellence. --- ### **Manufacturing & Capacity Expansion** Aether operates a multi-site, multi-chemistry, and flexible manufacturing network using both **batch and continuous processes**. - **Current Installed Capacity:** 7,896 MTPA across Sites 2 and 3 - **Key Facilities:** - **Site 3 (5,250 sq m):** Produces BFA, IDB, 10MISB; commercialized ISBCC. - **Site 4 (Sachin):** Commissioned March 2024; dedicated **Baker Hughes plant** for 6 oilfield products. Fully operational, growing order book. - **Site 5 (Panoli GIDC, 46 acres):** Greenfield facility under rapid development. First production block expected **Q3 FY26**. Supports LSM and future CEM projects. - **Site 3++:** Dedicated to **exclusive manufacturing for Milliken & Company** under a 10-year agreement. - **R&D Site (Site 1):** World’s largest pilot plant (per company claim), 26+ reactors (250L–4,000L), Siemens PCS7 DCS. - **Greenfield Projects:** - Site 3++ and Site 5 under fast-track execution. - **Site 5 will house 3–4 plants**, with products initially slated for Site 3 now transitioned here. - Multiple CEM contracts with European and American material science clients under finalization for Site 5. - **Automation & Certification:** - **DCS Systems:** Yokogawa Centum VP (manufacturing), Siemens PCS7 (pilot/CRAMS) - Certified under: ISO 9001, ISO 14001, ISO 45001, ISMS 27001, Indian GMP --- ### **Business Model & Strategic Shifts** Aether is strategically shifting towards **customer-driven contract manufacturing (CEM/CRAMS)** while maintaining a minimum 25–30% of R&D capacity for LSM to ensure innovation-led independence. - **Revenue Trend (CEM/CRAMS):** - Grew from **31.36% of revenue in FY2024 to 45.97% in FY2025** (CEM: 31.36% → 48%; CRAMS: 12.25% → 41% in Q2 FY26) - CRAMS grew **24.31% YoY**, CEM surged **71.39% YoY** (mainly due to Baker Hughes contract) - **Strategic Goal:** >**70% of future revenue** from contract-based models (CEM & CRAMS) - **Working Capital Target:** Reduce cycle to **~150 days** in next 2–3 years due to higher predictability from CEM contracts. --- ### **Key Client Partnerships & Contracts** - **Baker Hughes:** - Strategic Supply Agreement (SSA) for 6 high-value specialty chemicals ($2.5–$6/kg). - Combined volume: 15,000–19,500 MT/year. - **Aether is first contract manufacturing partner** for BH; Site 4 dedicated to this. - Expected sales: **₹35–40 crore in FY2026** - **Milliken & Company:** - 10-year exclusive agreement signed (Jul 2025). - **Site 3++ fully dedicated** to a key strategic product. - Scheduled operational by **end of FY2026**. - **Otsuka Chemicals (Japan):** - Long-term exclusive supply for two products. - Expected revenue contribution: **₹35–40 crores in FY2026**. - **Chemoxy International (SEQENS Group):** - 3-year take-or-pay exclusive manufacturing agreement. - Production of bio-based natural products (~100 MT/year). - Leverages Aether’s **continuous reaction technology**. - **Polaroid Films (Europe):** - 3+ year Master Supply Agreement, including R&D collaboration. - Expected revenue: **~₹1,215 million** over the term. --- ### **Diversification & Sustainability Initiatives** - **Product Diversification:** - Reducing dependence on agrochemicals; growing presence in **pharmaceuticals (45.6% of FY25 revenue), material sciences, and performance chemicals**. - Launching **3 new products at Site 5** targeting pharma, agrochemicals, and material sciences. - **Sustainability Leadership:** - **31 MW solar power capacity** (world’s largest solar-powered chemical plant in Surat). - Covers **>75% of electricity needs**, saving ₹120+ million/year. - Operating a **Zero Liquid Discharge (ZLD)** plant and **bio-diesel energy generation**. - Focused on **green chemistry** principles: reduce, recover, recycle, reuse (4R strategy). - Energy costs: ~5.6% of revenue, mitigated through solar and efficient design. - **New Business Segments:** - **Battery Materials:** Strategic agreement with global lithium-ion battery maker for **electrolyte additives**. - **Sustainable Materials:** Commercializing **Converge® polyols** (with H.B. Fuller & Aramco) and **circular plastics** (with Novoloop). --- ### **Technology & Chemistry Capabilities** Aether leverages **8 core chemistries**: 1. Grignards & Organolithiations 2. Ethylene Oxide Chemistry 3. Ethylene Oxide-Isobutylene Chemistry 4. Hydrogenation/Catalysis 5. Heterogeneous Catalysis 6. Exothermic Chemistry 7. Cross Coupling Chemistry 8. Olefin Metathesis/Polymerization **7 Primary Engineering Technologies:** - Continuous/Batch Reaction - High Pressure & Cryogenic Reactions - Fixed Bed (Gas/Liquid Phase) - Wiped Film & Short Path Distillation - High Vacuum Distillation Processes are highly automated, with advanced analytical tools, simulation platforms, and digital R&D systems adopted to **optimize development cycles**. --- ### **Governance, Safety & Vision** - **Total Employees:** Over **1,000**, including 286 R&D personnel. - **Safety:** - Hazard and operability studies (HAZOP) conducted regularly. - Plant-wide DCS automation, gas detection, foam monitors, 700 m³ water storage. - **Collaborative fire reserve of 2,000+ m³** with neighboring plants. - **Regulatory Compliance:** Passed **33 audits in 9M FY25**, with full regulatory restart of Site 2 after GPCB clearance in Jan 2025.